These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7308028)

  • 1. Chronic toxicity and carcinogenicity of cytostatic N-nitroso-(2-chloroethyl) ureas after repeated intravenous application to rats.
    Eisenbrand G; Habs M
    Dev Toxicol Environ Sci; 1980; 8():273-8. PubMed ID: 7308028
    [No Abstract]   [Full Text] [Related]  

  • 2. The carcinogenicity of 1-methyl-3(p-bromophenyl)-1-nitrosourea (Br-MPNU).
    Warzok R; Martin J; Mendel J; Thust R; Schwarz H
    Arch Geschwulstforsch; 1983; 53(4):329-33. PubMed ID: 6625867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():137-49. PubMed ID: 6944256
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells.
    Drewinko B; Loo TL; Gottlieb JA
    Cancer Res; 1976 Feb; 36(2 Pt 1):511-5. PubMed ID: 1260749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
    Eisenbrand G
    IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinogenicity of 1-(4-amino-2-methylpyrimidine-5-yl)-methyl-3-(2-chloroethyl)-3- nitrosoureahydrochloride and three related N-nitroso derivatives following repeated intravenous administration to male Wistar rats.
    Berger MR; Petru E; Schmähl D
    Oncology; 1988; 45(2):127-33. PubMed ID: 3162572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of nitrosourea compounds in cancer chemotherapy].
    Robak T
    Pol Tyg Lek; 1982 Sep; 37(36):1067-70. PubMed ID: 6763214
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumorigenic effect of topical mechlorethamine, BCNU and CCNU in mice.
    Zackheim HS; Smuckler EA
    Experientia; 1980 Oct; 36(10):1211-2. PubMed ID: 7418808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New experimental approaches to reducing carcinogenicity in animals by modifying regimens.
    Habs M; Schmähl D
    IARC Sci Publ; 1986; (78):177-85. PubMed ID: 3108155
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinogenicity of nitrosotrialkylureas in Fischer 344 rats.
    Lijinsky W; Reuber MD; Blackwell BN
    J Natl Cancer Inst; 1980 Aug; 65(2):451-3. PubMed ID: 6931260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenicity of chlorinated nitrosotrialkylureas in rats.
    Lijinsky W; Taylor HW
    J Cancer Res Clin Oncol; 1979 Jun; 94(2):131-7. PubMed ID: 468904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of broad spectrum of tumors by ethylnitrosourea in mice and the modifying role of age, sex, and strain.
    Vesselinovitch SD; Rao KV; Mihailovich N; Rice JM; Lombard LS
    Cancer Res; 1974 Oct; 34(10):2530-8. PubMed ID: 4412784
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative studies with different doses of N-nitrosomorpholine, N-nitrosopiperidine, N-nitrosomethylurea, and dimethylnitrosamine in Syrian golden hamsters.
    Haas H; Mohr U; Krüger FW
    J Natl Cancer Inst; 1973 Oct; 51(4):1295-301. PubMed ID: 4745858
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of dose fractionation on the carcinogenicity of chemical substances].
    Turusov VS
    Eksp Onkol; 1984; 6(3):15-20. PubMed ID: 6389085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of (2-haloethyl)nitrosoureas on DNA. Isolation and reactions of postulated 2-(alkylimino)-3-nitrosooxazolidine intermediates in the decomposition of 1,3-bis(2-chloroethyl)-, 1-(2-chloroethyl)-3-cyclohexyl-, and 1-(2-chloroethyl)-3-(4'-trans-methylcyclohexyl)-1-nitrosourea.
    Lown JW; Chauhan SM
    J Med Chem; 1981 Mar; 24(3):270-9. PubMed ID: 7265113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carcinogenicity in BD-IX rats of 7 homologues of N-nitroso-N-n-alkylureas in different stages of postnatal development (author's transl)].
    Ivankovic S; Klimpel F; Wiessler M; Preussmann R
    Arch Geschwulstforsch; 1981; 51(2):187-203. PubMed ID: 7271429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticarcinogenic effect of palustran on development of tumors induced by 3-(1-alpha-L-arabinopyranosyl)-1-methyl-1-nitrosourea (AMNU) in rats].
    Sherenesheva NI; Fin'ko VE; Blanko FF; Alieva TA; Bedrina EN; Gogoleva IA; Klochkova TI
    Biull Eksp Biol Med; 1998 May; 125(5):566-8. PubMed ID: 9644561
    [No Abstract]   [Full Text] [Related]  

  • 18. The induction of tumors of the nervous system with intravenous methylnitrosourea.
    Swenberg JA; Koestner A; Wechsler W
    Lab Invest; 1972 Jan; 26(1):74-85. PubMed ID: 4333080
    [No Abstract]   [Full Text] [Related]  

  • 19. [The pre- and postnatal carcinogenic effect of 3,3-diethyl-1-methyl-1-nitrosourea (DEMNU) in rats following intravenous application].
    Wagner U; Schreiber D; Thust R; Schneider M
    Arch Geschwulstforsch; 1990; 60(3):179-86. PubMed ID: 2369280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenicity of N-nitroso-3-hydroxypyrrolidine and dose-response study with N-nitrosopiperidine in rats.
    Eisenbrand G; Habs M; Schmähl D; Preussmann R
    IARC Sci Publ; 1980; (31):657-66. PubMed ID: 7228288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.